Search PubMed⌕ Search

Biomedical subjects

D Köhler

Publications and source records attributed to D Köhler.

At least 73 records · Page 4Linked to original sources
PubMed1999

[Relevance of deep venous thrombosis of the leg in patients with acute exacerbated COPD].

BACKGROUND: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with dyspnoea and, consequently, reduced mobility. Immobility is a recognised risk factor for deep venous thrombosis (DVT), but few data exist regarding the prevalence of DVT in acute exacerbation of COPD. Real-time B-mode ultrasonography (US) is a noninvasive screening-method for the diagnosis of DVT. We therefore used US to investigate the prevalence of DVT in patients with an acute exacerbation of COPD. METHODS: In a prospective cohort study 196 patients with COPD were studied (110 men, 86 female, age: 66.9 +/- 9.1 years, weight: 63.5 +/- 12.7 kg, forced expiratory volume in 1 second [FEV1]: 0.7 +/- 0.21, FEV1% of vital capacity [VC]: 37 +/- 6) in a respiratory intensive care unit on the day of admission. Patients with reduced mobility due to other diseases were excluded. All US were performed by one experienced person with a 5 MHz linear scanner. The veins of the lower extremity were subdivided into 3 segments: 1. The common femoral, 2. superficial femoral veins including the long saphenous vein and 3. the popliteal vein. RESULTS: In 21 of 196 COPD patients (10.7%) DVT were demonstrated; 18 of these were asymptomatic. Bilateral DVT were not found. In 6 patients additional diagnoses were obtained. There was no difference between patient with and without DVT with respect to age, hemoglobin, PO2, PCO2, pH, FEV1, VC or dyspnoea scale. CONCLUSIONS: DVT in the lower extremity, which was not detectable on clinical examination, was relatively common in patients with an acute exacerbation of COPD. All measured clinical variables (age, weight, dyspnoe-scale, lung function, hemoglobin and hematocrit and blood gases) failed to predict patients more likely to have DVT.

Acute Disease↗
PubMed1999

[Daytime mechanical ventilation in chronic ventilatory insufficiency].

BACKGROUND: Nocturnal hypoventilation is associated with chronic ventilatory insufficiency (CVI). Noninvasive mechanical ventilation (NIV) performed overnight relieves symptoms of hypoventilation and improves daytime blood gases in CVI. In order to test whether the efficacy of NIV depends on its being applied during sleep we conducted a prospective case controlled study comparing daytime mechanical ventilation (DV) in awake patients with nocturnal mechanical ventilation (NV) given in equal quantities. PATIENTS AND METHODS: We enrolled 34 clinically stable patients (age: 56.1 +/- 12.1 years, 20 female) with CVI due to both restrictive lung and chest wall disorders and neuromuscular disease. Using a prospective case-control design, matched subjects were allocated alternately to DV and NV. RESULTS AND CONCLUSIONS: There were no significant differences between the groups in the improvement of the measured parameters; (e.g. PaCO2; DV: from 57.6 +/- 4.3 to 44.0 +/- 4.6 mm Hg, NV: from 55.5 +/- 3.5 to 45.0 +/- 4.1 mm Hg, p < 0.0001). We conclude that in many respects, when compared to NV, DV in awake patients is equally effective for the treatment of CVI.

Adult↗
PubMed1999

[Continuous flow apnoeic ventilation via intratracheal oxygen insufflation].

BACKGROUND: In patients with disturbed gas-exchange (e.g. COPD) intratracheal oxygen insufflation (ITO2) improves oxygenation and reduces the minute ventilation. We use a bronchoscopic technique of intratracheal catheter placement in unintubated patients. In a patient with a pink-puffer emphysema after endoscopical insertion of the catheter ITO2 induced a "continuous flow apnoeic ventilation" (CFAV). CASE REPORT: A patient (female, 58 years) with a pink-puffer emphysema was admitted to the ICU with acute on chronic respiratory failure due to acute laryngitis. Because of laryngitis associated upper airway obstruction a non-invasive mechanical ventilation could not be performed. The ensuing high flow ITO2 (10 l/min) induced a CFAV characterized by no chest wall movement and adequate ventilation as reflected by stable, elevated PaCO2 (between 118 and 125 mm Hg), which could be maintained for 4 hours. After an ensuing short-term invasive mechanical ventilation and the administration of high dose glucocorticoids the patient was successfully extubated and the clinical status improved continuously. CONCLUSION: In a patient with an acute on chronic respiratory failure due to end-stage emphysema ITO2 induced CFAV and stabilized the clinical status. Especially in patients with end-stage emphysema, who are likely to be difficult to be weaned from the respirator ITO2 may be a feasible technique in order to bridge an emergency situation.

Emphysema↗
PubMed1999

[Importance of blood transfusion in anemic patients with COPD and unsuccessful weaning from respirator].

BACKGROUND: Imbalance of load-capacity relationship in severe COPD may lead to ventilatory failure. Additionally, in such patients, anemia may aggravate the ventilatory load. In this retrospective study we investigated whether anemia patients undergoing long-term ventilation benefit from transfusion. CASE REPORTS: We studied 5 anemic patients (hemoglobin: 8.7 +/- 0.8 g/dl) with COPD in whom trials of weaning from the ventilator had been unsuccessful. After transferral to our regional weaning centre, blood was transfused to increase the hemoglobin value to approximately 12 g/dl or higher. Subsequently, all patients could be successfully weaned within a short period. CONCLUSION: We conclude that in difficult to wean anemic patients blood transfusion should be considered and may lead to successful weaning.

Adult↗
PubMed1999

[Evaluation of daily activity in patients with COPD].

BACKGROUND: Recently we could show that the daily activity in patients with hypercapnic respiratory failure as judged by the total amount of movements per day increased by 120% after 3 months of non-invasive mechanical ventilation. This study was designed to evaluate the reproducibility of the result of a movement detector in measuring daily activity of patients with COPD. PATIENTS AND METHODS: 25 outpatients (11 females, 56 +/- 12 years old) with stable non-hypercapnic COPD (FEV1 = 47 +/- 9% predicted) were examined twice during a 7 days lasting interval, one month apart using a pedometer. RESULTS AND CONCLUSIONS: The repeatability of the activity counts in the non-hypercapnic COPD patients was high (1st study period: 3,781 +/- 2,320 movements/d, 2nd study period: 3,626 +/- 2,149 movements/d) and in these patients activity correlated significantly with FEV1 (r = 0.54, p = 0.006).

Activities of Daily Living↗
PubMed1999

[Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].

Intrapleural administration of fibrinolytic agents has been in use for fifty years; it has, however, been of clinical importance only for the last twenty years. Parallel to clinical reports procoagulant and fibrinolytic activities in pleural effusions are studied. Most types of pleural injury are characterised by fibrin deposition in the pleural space promoted by concurrent local abnormalities of pathways of fibrin formation and its clearance. Many of the studies of intrapleural fibrinolytics are uncontrolled and retrospective or small and are therefore of limited statistical value. Only five of the studies which are presented in the table are controlled and comparative studies. Intrapleural fibrinolytic therapy was used in exudative fibrinous multi-loculated pleural effusions, pleural empyemas and haemothorax. The global success rate of the studies cited were between 44% and 100%, in most cases more than 80%. The great differences in success rates are due to variations in the pleural diseases and stages of the clinical course, different success criteria, different dosages of fibrinolytic agents, different durations of clamped chest tube drainage and different starting points of therapy during the hospital course. The number of patients enrolled in each study ranged from 8 to 98, the number of children ranged from 2 to 9. Intrapleural fibrinolytic treatment is associated with rare adverse effects. There is no significant systemic fibrinolytic activity of intrapleural fibrinolysis. Intrapleural administration of streptokinase has been reported to lead to antibody formation. Hence, intrapleural fibrinolytic therapy is a useful adjunct in the management of exudative fibrinous multi-loculated pleural effusions, pleural empyemas and haemothorax. There is an increased volume of pleural fluid drainage during the treatment phase, and intrapleural fibrinolysis may reduce the need for more invasive surgical procedures. On the basis of the data of literature we recommend to use a single daily dose of 250,000 U streptokinase or 100,000 U urokinase in 50-100 ml normal saline instilled into a chest tube and to maintain dwell times of 2 to 4 hours. Therapy can be continued up to 2 weeks. The pleural space can be drained by large bore chest tubes or small drainage catheters, both radiologically guided, without preference for one method.

Empyema, Pleural↗
PubMed1999

[Effect of intermittent ventilation on pulmonary hypertension in chronic respiratory failure].

Intermittent non-invasive (or nocturnal mechanical ventilation) eliminates symptoms of hypoventilation and improves gas exchange in patients with chronic respiratory failure. Performing right heart catheterisation we studied the influence of nocturnal mechanical ventilation on pulmonary hemodynamics. We investigated 20 patients with restrictive thoracic diseases (Post-TBC: n = 9, scoliosis: n = 11, PaCO2: 59.8 +/- 7.6 mmHg) and 13 patients with COPD (n = 13, PaCO2: 58.5 +/- 7.8 mmHg). All patients were mechanically ventilated in controlled mode. During the study the medication was not changed; COPD patients with long-term oxygen maintained this therapy. Right-heart catheterisation was performed immediately before and after 1 year nocturnal mechanical ventilation. In patients with thoracic restriction NMV induced a marked reduction of pulmonary artery pressure (PAP) from 33.2 +/- 10.0 mmHg before to 24.8 +/- 6.2 mmHg after 1 year nocturnal mechanical ventilation. In the COPD group PAP increased from 25.3 +/- 6.0 mmHg before to 27.5 +/- 6.0 mmHg after 1 year nocturnal mechanical ventilation. In contrast to the COPD group in patients with chronic respiratory failure due to thoracic restriction nocturnal mechanical ventilation causes substantial reduction in pulmonary artery pressure after a one year application.

Carbon Dioxide↗
PubMed1999

[Scintigraphic demonstration of aspiration in long-term ventilation patients with tracheotomy].

The main complication of enteral feeding in prolonged mechanical ventilation via tracheostomy is the subsequent aspiration pneumonia. We used a scintigraphic method for the detection of enteral feeding aspiration and compared the results with clinical evidence of aspiration. The study population consisted of 62 consecutive tracheotomised patients (16 females, age: 64.1 +/- 11.1 years). The swallowing test was done in an upright or semirecumbent body position with the patients spontaneously breathing. The standard feed consisted of a liquid, semiliquid and solid meal which was labelled by 100 MBQ 99 TC. Scintigraphic aspiration (SA) was defined as positive if radioactivity was detected in the bronchial system. Clinical aspiration (CA) was defined as positive if there was cough, choking and distress after swallowing; furthermore, when receiving enteral feeding during suctioning or bronchoscopy. Both clinically significant aspiration (CA) and scintigraphic aspiration (SA) were found to be identical in 10 of 62 (16%) patients. CA, but not SA: 4/62 (6.5%). SA, but not CA (Subclinical aspiration): 4/62 (6.5%). Nor CA neither SA: 44/62 (71%) patients. Radiolabelled feed can be used as a feasible marker to detect aspiration. The test is a useful screening test and strategy to minimize aspiration. The scintigraphic method failed to identify all tracheotomised patients with clinically significant aspiration. However, scintiscanning did suggest that some patients had subclinical aspiration.

Deglutition↗
PubMed1998

[Value of orally administered retard morphine for therapy of severe pulmonary emphysema of the pink-puffer type. A pilot study].

BACKGROUND AND OBJECTIVE: In severe "pink puffer" emphysema the patients' physical capacity is limited by dyspnoea despite maximal application of established treatment. This pilot study investigated the effect of retarded morphine, taken orally for 10 days, on ventilation, dyspnoea, walking capacity and wakefulness. PATIENTS AND METHODS: Twenty clinically stable patients (11 men, 9 women, mean age 68.5 [50-81] years) with "pink puffer" emphysema were studied over a period of 10 days in a prospective, non-controlled trial of cross-over design. Criteria for inclusion in the study were: 1-second forced expiratory volume (FEV1) < 1 I, vital capacity < 50% and normocapnia. In addition to their existing therapy patients received either no further therapy or retarded morphine. Morphine dosage was increased to maximally 3 x 30 mg daily, depending on effectiveness and side effects, dyspnoea at rest and immediately after a 6-min walk (assessed with Borg's visual analog scale), maximal walking capacity were determined, as well as blood gases, respiratory minute volume and the respiratory drive (airway occlusion pressure [P0.1]), responsiveness of the respiratory pathways to CO2 and wakefulness (concentration, fatigue, interest in surroundings). RESULTS: Twelve patients completed the study (group A). In the remaining patients (group B) the test had to be stopped prematurely because of undesirable side effects or an exacerbation of the underlying infection. In group A, morphine (mean dosage: 49.2 +/- 28.4 mg/d) caused a reduction of PaO2, dyspnoea on activity, the resting minute respiratory volume, respiratory drive and CO2 response, and an increase in PaCO2, HCO3- and the 6-min walking distance. Morphine did not produce a change in subjectively evaluated vigilance and the blood pH. CONCLUSION: After strict patient selection oral morphine produced a reduction of exercise dyspnoea and an increase in walking capacity in half of the patients with severe pulmonary emphysema. There also occurred a slight rise in PaCO2 without any relevant respiratory acidosis or significant decrease in wakefulness.

Administration, Oral↗
PubMed1998

[Evolutionary quality assurance. A new concept for improving process and outcome quality].

BACKGROUND: The concept evolutionary quality assurance is a new, non-mandatory, open peer review process for in-patients settings. METHOD: Ten medical charts (with radiographs) from participating hospitals were randomly chosen and assessed using a prespecified questionnaire (total 134). Individual inadequacies had to be justified on a case by case level. Reviewer and reviewee are known by names, allowing subsequent discussions on content between reviewer and reviewee prior to a final judgement. The final analysis was performed anonymously and communicated to the participants after completion of the process. Patients had to give their consent to the review process. The report, however, is not part of the medical patient file, so that access is not warranted. For the first cycle, all lung clinics and departments throughout Germany were asked to participate. 35 chest hospital (approximately 50%) agreed to participate. RESULTS: Data analysis revealed that almost all detected inadequacies were apparent, i.e. discussions on the discordant interpretation of diagnostic and therapeutic strategies rarely occurred (0.25%). Final analysis of the evaluation performance of reviewers judged less than 5% and 14% judged more than 30% of all quality inadequacies. CONCLUSIONS: The quality assurance process is comparably cheap and can be implemented without delay, because standards for reference values are not required. The structure allows adaptation in all areas of clinical medicine.

Germany↗
PubMed1998

[Therapeutic strategies in respiratory insufficiency in amyotrophic lateral sclerosis. Possibilities and limits].

In the final stage of amyotrophic lateral sclerosis (ALS) the majority of patients develop chronic respiratory failure due to respiratory muscle weakness. The interaction between the patient with ALS and the physician should be characterized by continuous communication, especially with respect to the prospect of ventilatory failure and for support. The patient and his family must be informed thoroughly about the natural history and the prognosis of ALS, depending on the individual disease process. Already in the early stage of the disease coping strategies should be discussed so that imminent respiratory emergencies can be handled. If ALS patients are not informed about the acute respiratory insufficiency they run the risk of having to be intubated and mechanically ventilated over a long term. If dyspnea and hypersecretion dominate the final stage of ALS, the therapeutic strategy consists of the administration of morphine, insufflation of oxygen and bronchoscopic suction. Mechanical ventilation should only be initiated in the exceptional case. However, if dyspnea occurs in the early stage of the disease, when there is no bulbar paralysis and peripheral muscle function is intact, then noninvasive mechanical ventilation via mask may improve the quality of life substantially. Nevertheless, invasive mechanical ventilation via a tracheostomy should be avoided.

Advance Directives↗
PubMed1998

Blood transfusion facilitating difficult weaning from the ventilator.

We report a case series of five anaemic patients (haemoglobin: 8.7 +/- 0.8 g.dl-1) with chronic obstructive lung disease in whom trials of weaning from the ventilator were unsuccessful. After transfer to our regional weaning centre, blood was transfused to increase the haemoglobin value to 12 g.dl-1 or higher. Subsequently, all patients were weaned successfully. We conclude from our experience that in anaemic patients with chronic obstructive lung disease there should not be a fixed transfusion threshold. In anaemic patients in whom difficulty in weaning from the ventilator is experienced, blood transfusion should be tailored to the individual patient's needs. Transfusion in those with chronic obstructive airways disease may lead to successful weaning.

Adult↗
PubMed1998

Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease.

OBJECTIVE: To study in anemic patients with chronic obstructive pulmonary disease (COPD) whether blood transfusion reduces minute ventilation and work of breathing (WOB). DESIGN: We prospectively evaluated the minute ventilation and WOB in 20 anemic adults (hemoglobin of <11 g/dL). Ten patients had severe COPD and ten patients were without lung disease. Measurements were made before and after receiving red blood cell transfusion; post-transfusion measurements were made 24 to 36 hrs after the last transfusion. SETTING: The study was performed in the intensive care unit of a tertiary referral center for home mechanical ventilation and for patients considered difficult to wean from mechanical ventilation. PATIENTS: Twenty clinically stable patients (12 female, eight male) with chronic anemia were studied. Ten patients with COPD (mean forced expiratory volume in 1 sec: 0.55+/-0.1 [SD] L) were compared with ten patients without lung disease. All participants had adequate renal and left ventricular function. INTERVENTIONS: Patients received 1 unit of packed red blood cells for each g/dL that their hemoglobin value was less than an arbitrarily defined target value of 11.0 to 12.0 g/dL. Each unit was transfused over 2 hrs and < or =3 units in total was given. MEASUREMENTS AND MAIN RESULTS: Esophageal pressure was measured from a catheter which was positioned in the middle of the esophagus. Flow was measured using a pneumotachygraph connected to a mouthpiece while a nose clip closed the nostrils during the measurements. From these data, respiratory rate, minute ventilation, and inspiratory resistive WOB were computed. Arterial blood gas values, oxygen saturation, hemoglobin, and hematocrit were also measured, and oxygen content was calculated before and 24 to 36 hrs after transfusion. In patients with COPD, hemoglobin increased from 9.8+/-0.8 to 12.3+/-1.1 g/dL due to a mean transfusion of 2.2+/-0.4 (SD) units of red blood cells. There was a reduction in the mean minute ventilation from 9.9+/-1.0 to 8.2+/-1.2 L/min (p < .0001); correspondingly, WOB decreased from 1.03+/-0.24 to 0.85+/-0.21 WOB/L (p< .0001). The capillary P(CO2) increased from 38.1+/-6.0 to 40.7+/-6.8 torr (5.1+/-0.8 to 5.8+/-0.9 kPa) (p < .05). Similarly, capillary P(O2) changed from 56.9+/-8.9 to 52.8+/-7.0 torr (7.6+/-1.2 to 7.0+/-0.9 kPa) (p < .05). In anemic patients without lung disease, minute ventilation, WOB, and the capillary blood gas values did not change after increase of the hemoglobin by a similar degree. CONCLUSIONS: We conclude that red blood cell transfusion in anemic patients with COPD leads to a significant reduction of both the minute ventilation and the WOB. In these patients, transfusion may be associated with unloading of the respiratory muscles, but it may also result in mild hypoventilation.

Aged↗
PubMed1998

Prevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary disease.

Acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with dyspnea and, consequently, reduced mobility. Immobility is a recognized risk factor of deep-vein thrombosis (DVT), but few data exist regarding the prevalence of DVT in patients with acute exacerbation of COPD. Real-time B-mode ultrasonography (US) is a noninvasive screening method for the diagnosis of DVT. We therefore used US to investigate the prevalence of DVT in patients with an acute exacerbation of COPD. In a prospective cohort study, 196 patients with COPD were studied [110 males, 86 females, age: 66.9 +/- 9.1 years, weight: 63.5 +/- 12.7 kg, forced expiratory volume in 1 s (FEV1): 0.7 +/- 0.2 liters, and a ratio of FEV1 to vital capacity (VC): 37 +/- 6%] in a respiratory intensive care unit on the day of admission. Patients with reduced mobility due to other disease were excluded. All US were performed by one experienced person with a 5-MHz linear scanner. The views of the lower extremity were subdivided into three segments: (1) the common femoral, (2) superficial femoral veins including the long saphenous vein and (3) the popliteal vein. In 21 of 196 COPD patients (10.7%), DVT were demonstrated; 18 of these were asymptomatic. Bilateral DVT were not found. In 6 patients, additional diagnoses were: Baker's cyst (n = 3), inguinal lymph node (n = 1) and knee joint effusion (n = 2). There were no differences between patients with and with DVT with respect to age, hemoglobin, PO2, PCO2, pH, FEV1, VC or dyspnea scale. DVT in the lower extremity, which was not detectable on clinical examination, was relatively common in patients with an acute exacerbation of COPD. All clinical variables measured (age, weight, dyspnea scale, lung function, hemoglobin, hematocrit and blood gases) failed to predict patients more likely to have DVT.

Acute Disease↗
PubMed1997

[Anemia increases work of breathing in patients with lung disease].

BACKGROUND: Pulmonary diseases with marked disorders in gas exchange or chronic overload of the respiratory pump needs increased ventilatory requirements. Additionally in these patients anemic may aggravate the ventilatory load. We thereby evaluated whether in these patients treatment of anemia (red blood cell transfusion: RBCT) leads to an improvement of the ventilatory load in comparison to the anemic patients without pulmonary disease. PATIENTS AND METHODS: We examined 21 patients with an anemia (Hb < 11 g%, 12 men). Fifteen patients had a pulmonary disease (group A), 6 patients suffered from anemia without pulmonary disease (group B). Subsequently within 8 hours the patients got 2 to 3 RBCT. We studied the patients on the day of admission and 24 to 36 hours after transfusion. The patients kept bed rest for spontaneous breathing 1 hour prior to the actual examination without supplemental oxygen. Hemoglobin, hematocrit, respiratory rate, respiratory minute volume and arterial blood gases were measured. On the following day we repeated the same procedures. RESULTS AND CONCLUSIONS: Anemia in patients with an increased ventilatory requirement causes an additional increase of work of breathing. In these patients-in contrast to patients without compromised lungs-2.2 red blood cell transfusions lead to an impressive reduction of VE (about 20%) and correspondingly also to a reduction of WOB.

Aged↗
PubMed1997

[Endoscopic placement of an intratracheal oxygen catheter--description of a new method].

BACKGROUND: In patients with disturbed gas-exchange intratracheal oxygen insufflation improves oxygenation and reduces the minute ventilation. Until now the intratracheal oxygen insufflation was performed using a tracheostomy or a percutaneous transtracheal technique. We studied the acceptance and efficacy of the intratracheal oxygen insufflation using a bronchoscopic technique of intratracheal catheter placement. PATIENTS AND METHODS: Five COPD-patients (4 men, 55.2 +/- 10.3 years; FEV1: 0.9 +/- 0.31 = 30.3 +/- 5.5% debit, pO2: 56.2 +/- 10.3 mmHg, pCO2 +/- 43.1 +/- 4.8 mmHg). Procedure of catheter placement: Through a nasally passed bronchoscope a guide wire was inserted into the proximal part of one bronchus. When positioned at the point 2 to 3 cm proximal to the carina, the bronchoscope was marked with plaster at the nasal ostium in order to measure this distance. After removing the endoscope, the oxygen catheter was inserted proximal to the carina using the guide wire. Before and during the intratracheal oxygen insufflation (flow: 3 l/min) minute ventilation, tidal volume, breathing frequence, blood gases and the subjective scores (using a visual analogue scale) were measured. RESULTS: Apart from one patient with a tolerable spontaneous declining urge to cough irritation the catheter was tolerated well during the study. Whereas pCO2 remained stable during the ITO2 (before ITO2: 43.1 +/- 4.8 mmHg; after 1 hour ITO2: 44.3 +/- 4.8 mmHg), the oxygenation improved (pO2: 56.2 +/- 10.3; 81.4 +/- 19.6 mmHg) and the minute ventilation decreased (7.5 +/- 1.8; 5.4 +/- 1.3 l/min) by approximately 28%. CONCLUSION: The bronchoscopic application of the intratracheal oxygen catheter was characterized by high acceptance, low invasiveness and immediate function. Furthermore, the minute ventilation and work of breathing respectively decreased to a relevant degree.

Adult↗